OpenEvidence grows amid questions about its ad-funded medical AI

OpenEvidence is an advertising-supported AI chatbot startup valued at $15 billion. Its founder says two-thirds of US physicians use the tool, according to the Financial Times, which reports debate about its effect on patient care. Ars Technica reports that the company's growth comes despite questions about accuracy and advertising.

Covered by 2 publishers within 11 hours of the first report.

• Ars Technica: The $15 billion ad-powered AI startup your doctor may already be using

Reporting2

FT Financial Times The $15bn ‘viral’ AI start-up changing how American doctors treat patients 12:00 AM

AT Ars Technica The $15 billion ad-powered AI startup your doctor may already be using · Rafe Rosner-Uddin, Financial Times 11:14 AM

Related

TRP OpenEvidence, Johns Hopkins Partner to Bring AI Into Medical Training and Patient Care October 13